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Background: In humans, adipose tissue (AT) originating from different depots shows varying gene expression
profiles. In horses, the risk of certain metabolic disorders may also be influenced by the impact of specific AT
depots. Macrophage infiltration in human and rat AT is considered to be a source of inflammatory changes. In
horses, this relationship has not been extensively studied yet. Reverse transcription quantitative real-time polymerase
chain reaction (RT-qPCR), a useful method to evaluate differences in mRNA expression across different tissues, can be
used to evaluate differences between equine AT depots. For a correct interpretation of the RT-qPCR results, expression
data have to be normalized by the use of validated reference genes. The main objectives of this study were to compare
mRNA expression of inflammation-related genes, as well as adipocyte morphology and number between different
equine AT depots; and in addition, to investigate the presence of antigen presenting cells in equine AT and any
potential relationship with adipokine mRNA expression.
Results: In this study, the mRNA expression of inflammation-related genes (leptin, chemokine ligand 5, interleukin 1β,
interleukin 6, interleukin 10, adiponectin, matrix metalloproteinase 2, and superoxide dismutase 2) and candidate
reference gene stability was investigated in 8 different AT depots collected from the nuchal, abdominal (mesenteric,
retroperitoneal, and peri-renal) and subcutaneous (tail head and loin) AT region. By using GeNorm analysis, HPRT1,
RPL32, and GAPDH were found to be the most stable genes in equine AT. The mRNA expression of leptin, chemokine
ligand 5, interleukin 10, interleukin 1β, adiponectin, and matrix metalloproteinase 2 significantly differed across AT depots
(P < 0.05). No significant AT depot effect was found for interleukin 6 and superoxide dismutase 2 (P > 0.05). Adipocyte
area and number of antigen presenting cells per adipocyte significantly differed between AT depots (P < 0.05).
Conclusions: Adipose tissue location was associated with differences in mRNA expression of inflammation-related genes.
This depot-specific difference in mRNA expression suggests that the overall inflammatory status of horses could be
partially determined by the relative proportion of the different AT depots.
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Adipose tissue (AT) can be divided into brown and white
AT [1]. The latter is now recognized as being more than
an energy storage site. It is accepted as a highly active
metabolic and endocrine organ [2,3] comprising different
cell types (adipocytes, pre-adipocytes, endothelial cells, fi-
broblasts and macrophages) [4] that actively secrete pro-
teins involved in the regulation of energy, as well as
neuroendocrine, autonomic, and immune functions [5].* Correspondence: lien.bruynsteen@ugent.be
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distribution, and reproduction in any mediumThese different cell types may contribute to the secretion
of the pro-inflammatory cytokines tumor necrosis factor
alpha (TNF-α), interleukin 1 (IL-1), interleukin 6 (IL-6),
chemokine ligand 5 (CCL5), and anti-inflammatory cyto-
kine interleukin 10 (IL-10), as well as hormones such as
resistin, leptin, and adiponectin that are involved in the in-
flammatory response and insulin sensitivity [5-7].
The AT also secretes matrix metalloproteinases (MMPs,
e.g. MMP-2 or gelatinase A, MMP-9 or gelatinase B [8],
and MMP-1,3,7, [9]) which have a functional role in the
development of the AT [10] and are important for the
extracellular matrix remodelling, which occurs during
obesity-mediated AT formation, at least in mice [11].tral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Information on the horses involved in this study
Horse Breed Age
(years)
Nutritional
status
1 German riding horse 16 overweight to
obese
2 Dutch riding horse 20 normal
3 Belgian riding horse 1 normal
4 French riding pony, breed
Haflinger
17 obese
5 Selle Français 10 normal
6 French Thouroughbred 12 normal
7 Royal Dutch Sport Horse (KWPN) 11 normal
8 Belgian trotter 3 normal
9 Belgian Warmblood (BWP) 21 overweight to
obese
10 Dutch riding horse 25 overweight to
obese
11 Dutch riding horse 11 overweight to
obese
12 French trotter 15 overweight to
obese
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vealed that over 90% of the adipokine release by AT, except
for adiponectin and leptin, could be attributed to non-fat
cells. When excessive amounts of AT are deposited, inflam-
matory markers in the circulation can rise as result of the
adipokine secreting ability of AT. Cinti and colleagues [13]
demonstrated that > 90% of all macrophages in white AT
of obese mice and humans were localized around dead adi-
pocytes, forming crown-like structures (CLS). Vick and
colleagues [14] first demonstrated an association between
obesity and increased inflammatory markers (TNF-α and
IL-1) in horses, although age was also an important and
possible confounding factor. Currently, there is some con-
troversy whether obesity in horses is or is not associated
with low grade inflammation [14-16] and there is no evi-
dence whether CLS do or do not form in the obese horse.
Adipocyte size is positively correlated with frequency
of adipocyte death, macrophage numbers, as well as CLS
in visceral and subcutaneous (SC) depots in mice
[13,17], and leptin mRNA expression in humans and
cattle [18,19]. To the authors’ knowledge, size of adipo-
cytes originating from different horse AT regions has
not been previously reported.
The specific site of AT deposition is clinically very im-
portant. Humans with a higher accumulation of visceral
fat are at a higher risk for the development of obesity-
related metabolic disorders [20]. Similarly in horses, it
has recently been demonstrated that expression of glu-
cose transporters was influenced by AT location in insu-
lin sensitive and insulin resistant individuals [21]. It has
also been suggested in equidae that AT distributed spe-
cifically on the crest of the neck could indicate or con-
tribute to hyperinsulinemia, insulin resistance (IR), and/
or an increased risk for laminitis [22,23]. Therefore, clin-
ical interest on AT in this region is increased in horses
[22,24]. Burns and coworkers [24] found no differences
in pro-inflammatory cytokine IL-1β and IL-6 mRNA ex-
pression between insulin resistant and insulin sensitive
horses. Higher mRNA concentrations of these two cyto-
kines, however, were found in the nuchal ligament AT
compared to the other AT depots sampled in that study.
Our hypothesis was that mRNA expression of
inflammation-related genes varied across AT depots.
Therefore, the first aim of this study was to compare
adipocyte size and mRNA expression between different
equine AT depots with special interest in the nuchal AT
region. The second aim was to investigate the presence
of antigen presenting cells in equine AT and any poten-
tial relationship with adipokine mRNA expression.
Results and discussion
Animals
A variety of different breeds was chosen for this study
(Table 1). Average age was 14 ± 7 years.Blood analysis
Average glucose, insulin, and leptin levels were 106 ±
16 mg/dl, 5.9 ± 0.9 mU/l, and 3.3 ± 1.4 ng/ml respectively.
Candidate reference gene selection and GeNorm analysis
To study depot-related variation in mRNA expression in
AT, a very sensitive and specific technique is required,
such as RT-qPCR [25], because of the low yield of
mRNA isolated from AT [26]. However, before compar-
ing mRNA expression profiles across samples, correction
for variables such as quality and quantification of the
starting material and enzymatic efficiencies must be car-
ried out [26-28]. Consequently, the need for accurate
data normalization is crucial [29]. In human AT, obesity
and type 2 diabetes can exert a detectable influence on
reference gene expression in SC and visceral fat depots
[30]. This demonstrates that the expression level of ref-
erence genes is influenced by body region and health
status of the test subject.
The efficiency of each RT-qPCR run was calculated
from a relative standard curve based on a 5-point 5-fold
cDNA dilution series, and ranged between 93 and
102.5%. Linear correlation coefficients varied between
0.996 and 0.999.
One sample from the neck region, two from the SC
region, and four from the abdominal region showed con-
sistently higher transcription levels (Cq value: the frac-
tional PCR cycle at which the fluorescent signal
significantly rises above the background signal [31])
compared to the other samples. Amplification problems
were considered to be the cause as the RNA quantity
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same region (Experion analysis). These 7 AT samples
were therefore excluded from further analysis. Tran-
scription levels across all AT studied were almost similar
for ACTB, GAPDH, and RPL32, which had higher Cq
values than HPRT1, SDHA, and TUBA4A. The raw gene
expression data from the genes of interest were normal-
ised using the geometric mean of the most stable candi-
date reference genes GAPDH, HPRT1, and RPL32.
Depot-specific mRNA expression
The present study investigated the AT depot related
mRNA expression of inflammation-related genes in
horses of different breeds, different ages, and with vary-
ing body condition or nutritional status. Adipokine ex-
pression was primarily studied at the transcription level,
which does not necessarily reflect the protein level and/
or its activity. It should be mentioned that AT is made
up of multiple cell types [4]. The aim of mRNA expres-
sion was not to examine the individual cell populations,
but to consider AT as a whole [12].
Leptin mRNA expression was significantly higher in
the three neck samples compared to the mesenteric AT
samples (Neck (N) ¼, N ½, N ¾: P = 0.034, 0.008, and
0.015 respectively). In contrast, CCL5 and IL-10 showed
significantly lower mRNA expression in the nuchal AT
compared to the mesenteric AT (N ¼, N ½, N ¾; P = 0.009,
0.009, 0.019 for CCL5, and 0.032, 0.008, 0.009 for IL-10
respectively). A significant lower expression of adipo-
nectin mRNA was found in the tail head AT region
compared to the nuchal AT (N ¼, N ½, N ¾: P = 0.010,
0.014, and 0.004 respectively), retroperitoneal (P = 0.003),
and peri-renal AT region (P = 0.009). Pro-inflammatory
cytokine IL-1β mRNA expression was significantly lower
in the loin AT compared to the mesenteric and peri-renal
AT (P = 0.004). A trend for lower mRNA expression was
found in the retroperitoneal AT (P = 0.074). The MMP2
mRNA expression was significantly lower in the peri-renal
region compared to AT originating from N ¼ (P = 0.019),
N ½ (P = 0.006), tail head (P = 0.004) and loin region
(P = 0.008). Mesenteric AT had a significantly lower
MMP2 mRNA expression compared to N ½ (P < 0.001),
tail head (P = 0.004) and loin AT (P = 0.001). Retroperiton-
eal AT had a significantly lower MMP2 mRNA expression
compared to the loin AT (P = 0.014). Interleukin 6 tended
to have a higher mRNA expression in the N ½ AT com-
pared to mesenteric AT (P = 0.073). No significant AT
depot effect was found for superoxide dismutase (SOD) 2.
A correlation was found between plasma leptin and in-
sulin concentrations (P = 0.035; r = 0.610). There was
also a correlation between IL-6 and IL-1β in the nuchal
AT region (N ¼, N ½, and N ¾: P = 0.004, 0.001, 0.003;
r = 0.756, 0.827, 0.782 respectively) and the tail head region
(P = 0.007; r = 0.734). Higher leptin mRNA expression inthe nuchal AT region compared to the mesenteric AT sug-
gests that nuchal AT may contribute proportionally more
to the overall leptin concentration in the horse. The strong
correlation between leptin concentration and degree of IR
[32] supports the hypothesis that enlarged nuchal AT in-
deed is an important risk factor for IR [22,23]. In a study of
Liburt and coworkers, decreased IL-6 mRNA in nuchal AT
was associated with increased insulin sensitivity [33].
Higher nuchal AT IL-6 mRNA expression together with a
significant correlation between the expression of IL-6 and
IL-1β in the nuchal AT depot, could indicate that in
horses, the nuchal AT depot is an important contributor
for gene expression of these pro-inflammatory markers
whereas in humans, the visceral AT is responsible for this
[34,35]. If such expression leads to increased protein for-
mation, then an increase in the size of nuchal AT depot
could potentially contribute more to the total body inflam-
matory status. In humans, elevated inflammatory cytokines
such as TNF-α, IL-6, and IL-1 play important roles in the
development of obesity-associated IR [3,11,36]. If this is
also the case in horses, it would further confirm the link
between a high cresty neck score and IR.
Lower adiponectin mRNA expression in the SC region
compared to the abdominal and nuchal region suggests
that abdominal AT and nuchal AT may be more import-
ant for circulating adiponectin concentrations. Differ-
ences between gene expression in the different AT
depots and the protein levels in the blood can be caused
by differences at the translation level, which can be in-
fluenced by cytokines. Bruun and colleagues [37] showed
that TNF-α and IL-6 significantly decreased the human
adiponectin mRNA levels in vitro suggesting that
endogenous cytokines may affect adiponectin. In the
present study, however, no correlations between adipo-
nectin gene expression and cytokine mRNA expression
were found.
Chemotactic cytokine CCL5 mediates chemotaxis of
different leukocytes, depending on the tissue protein
levels. High levels of CCL5 can trigger cytokine release.
In humans, CCL5 production is upregulated by inflam-
matory cytokines, such as IL-1 [38]. In the present study,
CCL5, IL-10, and IL-1β mRNA expression was higher in
the abdominal region, although no correlations between
these cytokines were found. This could indicate that in
horses, other cytokines regulate CCL5 production.
Higher mRNA expression of CCL5, IL-10, and IL-1β in
the abdominal AT suggests that this AT depot may be
more important for the circulating levels of these cyto-
kines. This is in contrast with the findings from Burns
and coworkers [24] who found higher IL-1β mRNA ex-
pression in the nuchal ligament AT compared with the
other depots sampled in that study. It has been sug-
gested that different reference genes should be tested in
each study setup to find the most suitable one not
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date reference gene selection was different in the present
study (HPRT1, RPL32, and GAPDH) and the Burns’
study (β-actin and β2-microglobulin), it may mean that
results from both studies cannot be simply compared.
In mice, many MMPs are expressed by AT and stromal
vascular cells in a depot-specific manner [40]. Higher
MMP-2 mRNA expression in the SC AT suggests that in
horses, this AT depot is more stimulated to differentiate
pre-adipocytes into adipocytes [10,41] and extracellular
matrix remodeling [11].
In conclusion, different mRNA expression of
inflammation-related genes in different AT depots sug-
gests that AT depots may be a driving force for total
body inflammation. It is possible that if more fat is de-
posited in an AT depot with high mRNA expression
levels of pro-inflammatory cytokines, such as nuchal AT
with high leptin and pro-inflammatory IL-6 mRNA ex-
pression, this may contribute to a greater overall inflam-
mation in that individual horse than if the fat had been
deposited in an AT depot with a low mRNA expression
of pro-inflammatory cytokines. Further research into the
final translation of mRNA expression of inflammation-
related genes into adipokines will be necessary to cor-
rectly evaluate the impact of fat deposition at specific
places in the horse body.
Histology and immunohistochemistry
To the authors’ knowledge, adipocyte size and area in
cross-section in different AT regions in the horse body
have not been previously reported.
Adipocyte area and number of antigen presenting cells
(APC)/adipocyte could not be determined in 10 samples
from different AT depots in 6 different horses due to
technical cutting and staining difficulties (N ¼ AT for
horse number 4; N ¾ AT for horse number 8; tail head
AT for horse number 3; mesenteric AT for horse number
3,4,7,8 and right kidney AT for horse number 2,7,9).
Negative controls using isotype-matched nonsense anti-
body showed no staining.
Average adipocyte size was 70 ± 7 μm, with the largest
average adipocyte diameter being found in peri-renal AT
(82 ± 14 μm). Average adipocyte area in cross-section
was 3980 ± 1355 μm2. Peri-renal adipocyte area (5370 ±
1919 μm2) was significantly higher compared to N ½
(3116 ± 556 μm2; P < 0.001), N ¼ (3195 ± 831 μm2,
P = 0.003) and tail head adipocyte area (3537 ± 1375 μm2,
P = 0.022) (Figure 1). Retroperitoneal adipocyte area
(4795 ± 1610 μm2) was significantly higher than N ½
(3116 ± 556 μm2; P = 0.020) adipocyte area. A significant
lower number of APC/adipocyte was found in the N ½
AT compared to the loin AT (P = 0.024) (Figure 2).
Capping structures (dead adipocytes engulfed by APC)
(Figure 3), similar to CLS (dead adipocytes surroundedby macrophages [17]) in mice), were found in 6 horses
in 4 different AT depots (N ¼, N ½, loin, and peri-renal).
In 2 horses (number 3 and 4) CLS were found in mul-
tiple AT depots.
Clear differences in adipocyte area between AT depots
were found, which is in accordance with the findings in
other species [42-44]. Differences in adipocyte area can
influence mRNA expression [45-47]. Significant correla-
tions between mRNA expression of inflammation-
related genes and adipocyte area were also found in the
present study between multiple AT depots (N ¼, N ¾, tail
head, mesenteric, retroperitoneal, and perirenal) and mul-
tiple genes (adiponectin, CCL5, SOD, IL-10, leptin, and
MMP2), although no clear pattern could be determined.
In the subcutaneous region, APC/adipocyte was high
compared to the nuchal and abdominal region. In
humans, this is related to high adipocyte death and CLS
formation [13], but in the current study, this relationship
was not found. Macrophage inflammation in AT is also
correlated with inflammation in humans [48,49].
This is the first study describing capping structures
(adipocytes surrounded by APC) in the horse (Figure 3),
probably similar to CLS in mice and humans [13,17].
One limitation of the present study was the staining
method used, as this labeled MHC II molecules, which
are not exclusively expressed on macrophages, but also
on other APC such as monocytes, B-cells, and dentritic
cells [50,51].
Conclusions
Despite the fact that mRNA levels of inflammation-
related genes were studied instead of protein levels, still
interesting conclusions concerning the deposition of fat
in various depots in horses could be drawn. The inflam-
matory profile in AT clearly varies with its location in
the horse’s body in horses of different breeds varying in
age and nutritional status, suggesting that the total in-
flammatory status of the horse may be at least partly a
reflection of the relative contribution of each AT. The
factors driving the interindividual differences in AT dis-
tribution thus warrant further investigation.
Methods
Study animals
Twelve horses, due to be euthanized for non-research
purposes, were selected at a local abattoir. Horses were
chosen so that : 1) they were all geldings to exclude po-
tential gender-related gene expression [52]; 2) they rep-
resented a variety of different breeds presented at the
abattoir (Table 1); 3) they showed no obvious lameness
or overt laminitic rings; 4) they all had healthy appear-
ance; 5) they ranged in their nutritional status (as scored
visually by 2 experienced veterinarians) from normal to
obese (Table 1); and 6) they ranged in age from 1–25 years
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Figure 1 Mean adipocyte area of equine adipocytes. Data are reported as means ± SD. Peri-renal adipocyte area is higher compared to N ½
(P < 0.001), N ¼ (P = 0.003) and loin adipocyte area (P = 0.022). Retroperitoneal adipocyte area is higher than N ½ (P = 0.020) adipocyte area.
Superscripts (abc) indicate differences between adipose tissue location (P < 0.05). Missing values and outliers were excluded from this analysis (N3/4 8;
N1/4 4; TH 3; M 3,4,7,8; RK 2,7,9; L 11, RP 3). Abbreviations: N ¼, neck ¼; TH, tail head; L, loin; M, mesenteric; RP, retroperitoneal; RK, right kidney.
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cedure Royal Decree of January 16, 1988 concerning the
protection of animals at killing.
Sample collection
Blood samples were taken immediately post mortem from
the vena jugularis for the analysis of glucose (Vacuette®
tube, FX Sodium Fluoride/Potassium oxalate, 2 ml), as
well as insulin and leptin (Vacuette® tube, Z Serum Clot
Activator, 9 ml). Within 15 minutes after euthanasia, AT
samples were collected from the different sites: three sam-
ples in the nuchal region taken at ¼, ½, and ¾ of the dis-
tance between the poll and the withers; three abdominal
samples taken at the right kidney, retroperitoneally 10 cm
lateral to the linea alba, and at the mesenterium; and two0
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Figure 2 Antigen presenting cells (APC) per adipocyte in equine adip
performed to enable the identification of antigen presenting cells/HPF (AP
A lower amount of APC/adipocyte was found in the N ½ AT compared to
adipose tissue location (P < 0.05). Missing values and outliers were excluded
Abbreviations: N ¼, neck ¼; L, loin; TH, tail head; M, mesenteric; RP, retropesamples from SC AT taken at the level of the loin and
around the tail head. All samples were taken in duplicate.
Gene expression samples (thickness 0.4 – 0.5 cm) were
immediately submerged in RNAlater (Sigma-Aldrich,
AMBION, Inc., Austin, Texas, USA) for RNA preser-
vation and stored at 4°C for 24 hours and then stored
at −20°C until RNA extraction. Histology AT samples
were stored in formalin until further processing.
Blood sample analysis
Plasma glucose analysis was performed using a spectro-
photometric method based on glucose hexokinase [53]
(Architect C16000; Abbott, Abbott Laboratories, Abbott
Park, Illinois, USA). Serum insulin concentrations were
measured with an immunoradiometric assay test kit [32]TH M RP RK
abab
ab
ab
ose tissue. Major Histocompatibility Complex II (MHC II) stain was
C/HPF) in the different AT depots. Data are reported as means ± SD.
the loin AT (0.024). Superscripts (ab) indicate differences between
from this analysis (N3/4 8; N1/4 4; TH 3; M 3,4,7,8; RK 2,7,9; L 11, RP 3).
ritoneal; RK, right kidney.
a b
Figure 3 Capping structures in horse adipose tissue. Major Histocompatibility Complex II (MHC II) stain was performed to enable the
identification of antigen presenting cells in the different AT depots. Capping structures in the loin adipose tissue (a) and Neck ¼ (b) are indicated
with black arrows.
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Nivelles, Belgium). An implementation validation has
been carried out before use in horses. A dilution curve has
been designed (100–80 – 60 – 40 – 20 – 0% sample).
Theoretical and measured values were compared to
evaluate possible matrix-influences. Inter-assay variance
was < 4%, intra-assay variance in the high sample% was
9.2%, in the low sample% 1.9%. Leptin was measured
using a multispecies RIA kit (Merck Millipore., Billerica,
MA 01821, USA), previously validated for use in equine
plasma [54].
RNA isolation and cDNA synthesis
Total RNA was isolated using the RNeasy Lipid Tissue Mini
Kit (Qiagen®, AMBION, Inc., USA) and the TissueRuptor
(Qiagen) for complete sample disruption/homogenization,
as described in the manufacturer’s protocol. An on-column
DNase digestion (RNase-Free DNase Set, Qiagen) was
included and was empirically verified by a minus re-
verse transcription (RT) control reaction. RNA quantity
and purity (OD 260/280 ratio 1.9-2.1) were measured with
the ND-1000 spectrophotometer (NanoDrop, NanoDrop
Products, Wilmington, USA). The RNA quality was veri-
fied on an agarose gel and was assessed with the Ex-on
RNA StdSens Analysis Kit (Bio-Rad, Bio-Rad Laboratories
N.V., Hercules, USA) on an Experion Automated Electro-
phoresis System (Bio-Rad). The RNA quality indicator
(RQI) for the AT ranged between 7–8.5 and for liver be-
tween 9–9.5. Subsequently, the iScript cDNA synthesis kit
(Bio-Rad) was used to convert approximately 0.6 μg of
total RNA into cDNA, which was verified by a control
PCR.
Quantitative real-time PCR
All PCR reactions were performed in a 15 μl reaction vol-
ume on an iCycler iQ Real-Time PCR Detection System
(Bio-Rad) using 7.5 μl of Kapa SYBR Fast Bio-Rad qPCR
Master Mix (Sopachem, Kapabiosystems, Woburn, USA)supplemented with 2.5 μl of diluted cDNA. The addition
of RNAse free water and primer concentration varied ac-
cording to the primer used. The qRT-PCR measurements
for all samples were performed in duplicate and every run
included a no-template control.
The PCR program started with an initial denaturation
at 95°C for 3 minutes to activate the Taq polymerase,
followed by 40 cycles of denaturation at 95°C for 10 sec-
onds and a combined primer annealing/extension at the
primer specific annealing temperature for 30 seconds
during which fluorescence was measured. A melting
curve was constructed to verify the presence of a single
gene-specific amplicon and the absence of any primer
dimers by heating the samples from 70 to 95°C in 0.5°C
increments with a dwell time at each temperature of
10 seconds while continuously monitoring the fluores-
cence. The efficiency of each RT-qPCR run was calcu-
lated from a relative standard curve based on a 5-point
5-fold cDNA dilution series using pooled cDNA ob-
tained from AT in the neck, loin and tail head region
and liver. The RT-qPCR data from all genes were con-
verted to raw data as described in Erkens et al. [31]. Six
candidate reference genes were selected based on previ-
ous gene expression studies in human [30,55-57] and
bovine AT [58], as well as equine tissues (skin, blasto-
cysts, and lymphocytes) [59-61]. Candidate reference
gene primers for ACTB, HPRT1, RPL32, and TUBA4A
were used from Bogaert et al. (2006) [59]; GAPDH and
SDHA were used from Smits et al. [60].Determination of candidate reference gene expression
stability
Candidate reference gene expression stability was evalu-
ated with the M value of the geNorm algorithm [62]. The
most stable control genes (lowest variation in mRNA ex-
pression) have the lowest M value. The raw gene expres-
sion data from the genes of interest were then normalised
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Primers for the genes of interest
Primers for the genes of interest CCL5, IL-10, IL-1β, IL-
6, and SOD2 were used from Figueiredo et al. [63], and
for MMP2 from Loftus et al. [64]. For ADIPOQ and LEP,
primers were designed using Primer3 [65], while taking
primer specificity (Blast, [66]) and possible secondary
structures (Mfold, [67]) into account. As for the candidate
reference genes, all primer amplicons were sequenced
using the BigDye Terminator v3.1 Cycle Sequencing Kit
(Applied Biosystems) on an Applied Biosystems 3730xl
DNA Analyser. In addition, gel electrophoresis was per-
formed to check the formation of 1 amplicon of the ex-
pected size, and to control the absence of primer dimers.
Histology
Adipose tissue samples were fixated by immersion in 4%
paraformaldehyde, embedded in paraffin and sectioned.
Two five μm thick serial sections were obtained, the first
stained by hematoxylin and eosin (HE) to assess morph-
ology (adipocyte area) and the rest processed for immu-
nohistochemistry (see below). Adipocyte numbers were
counted in 10 high power fields (HPF) and the average
number of adipocytes was calculated per HPF. The sur-
face of 1 HPF (πr2 = π*250 μm2 = 196250 μm2) was di-
vided through the numbers of adipocytes/HPF to
calculate the mean surface area per adipocyte.
Immunohistochemistry
The presence of antigen presenting cells (APC) was eval-
uated by the use of Monoclonal Mouse Anti-Human
HLA-DR antigen, alpha-chain clone TAL.1B5 (Code No.
M0746; DakoCytomation, DakoCytomation, DK-2600,
Glostrup, Denmark). This stain colours the major histo-
compatibility II (MHC II) molecules that are expressed
on cells that serve as APC for CD4+, such as macro-
phages, monocytes, dendritic cells, and B cells [51,52].
Five μm-thick paraffin-embedded sections mounted on
coated slides (APES, 3-aminopropyltriethoxysilane) were
deparaffinised in xylene and with ethanol. Subsequently,
the slides were pre-treated according to the microwave
pressure cooker protocol for antigen retrieval (Citrate
Buffer 10x, pH 6.0, Klinipath CBB 999, Klinipath BV,
6920 AD, Duiven, Netherlands). The immunohistochemistry
was performed in an automated immunostainer (Dako,
Glostrup, Denmark; S/N S38-7410-01) according to the
manufactures protocol. For visualization the Envision+/HRP
mouse (DAB) kit (Dako Ref K4007, DakoCytomation,
DK-2600, Glostrup, Denmark) was used. Antibody dilu-
ent (Dako Ref S302283) was used to block hydrophobic
interactions. Sections were counterstained with Mayer’s
hemalum solution (Klinipath). A positive control (thoracicmass, high grade sarcoma) was included in each run to
ensure specificity. In negative controls, the primary anti-
body was replaced by a nonsense antibody of similar
isotype (Monoclonal Mouse Anti-Human Cytokeratin
Clones AE1/AE3). A second type of negative control
was carried out by using central nervous system (CNS)
parenchyma with the original primary antibody (Mono-
clonal Mouse Anti-Human HLA-DR antigen (alpha-chain
clone TAL.1B5), as within the normal CNS parenchyma,
MHC expression is minimal or absent [68]. To calculate
APC/adipocyte, number of APC/10 high HPF was divided
through the number of adipocytes/10 HPF.
Statistical analysis
Data are reported as means ± SD and significance was set
at P < 0.05. Statistical analyses were performed using IBM
SPSS Statistics 20. Gene expression data were analysed
with a general linear model by means of repeated mea-
sures with depot as within variable and animal as between
variable, followed by a Bonferroni post hoc test when a
significant difference between depots was detected. Hist-
ology data were analysed with a general linear model, uni-
variate analysis and Tukey post hoc test. Correlation
analysis (Pearson’s correlation test) was performed to
identify relationships between blood parameters, histology
findings and mRNA expression of cytokines.
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